Characteristics of and treatment strategies for preclinical rheumatoid arthritis

doi:10.3877/cma.j.issn.1674-0785.2018.08.009

Abstract

Abstract:

Rheumatoid arthritis, characterized by persistent inflammation and joint damage, affects 1% of the world's population. Several studies have shown that early treatment can reduce the severity of disease progression and increase the chances of sustained remission without disease-modifying antirheumatic drugs. Recent research data indicate that the disease process has been active in the pre-clinical stage (before arthritis can be detected clinically). However, it is not clear when RA will begin. This article reviews the latest advances in this field, explores the characteristics of pre-RA, identifies pre-clinical patients who may develop into RA, and discusses the limitations of our current understanding of pre-RA and the possible future research directions.

Key words: Rheumatoid arthritis, Preclinical stage, Arthralgia, Autoantibodies

Rui Wang, Weiwei Sun, Jiao Ai, Jing Liu, Guohua Yuan. Characteristics of and treatment strategies for preclinical rheumatoid arthritis[J]. Chinese Journal of Clinicians(Electronic Edition), 2018, 12(08): 472-476.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlcyszz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0785.2018.08.009

https://zhlcyszz.cma-cmc.com.cn/EN/Y2018/V12/I08/472

References 32

1	Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis [J]. Lancet, 2016, 388(10055):2023-2038.
2	Finckh A, Liang MH, van Herckenrode CM, et al. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: a meta-analysis [J]. Arthritis Rheum, 2006, 55(6):864-872.
3	Nell VP, Machold KP, Eberl G, et al. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis [J]. Rheumatology (Oxford), 2004, 43(7):906-914.
4	Demoruelle MK, Deane KD. Treatment strategies in early rheumatoid arthritis and prevention of rheumatoid arthritis [J]. Curr Rheumatol Rep, 2012, 14(5):472-480.
5	Gerlag DM, Raza K, van Baarsen LG, et al. EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis [J]. Ann Rheum Dis, 2012, 71(5):638-641.
6	Mankia K, Emery P. Preclinical rheumatoid arthritis: progress toward prevention [J]. Arthritis Rheumatol, 2016, 68(4):779-788.
7	Bos WH, Wolbink GJ, Boers M, et al. Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study [J]. Ann Rheum Dis, 2010, 69(3):490-494.
8	van Steenbergen HW, Aletaha D, Beaart-van DVL, et al. EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis [J]. Ann Rheum Dis, 2017, 76(3):491-496.
9	van de Stadt LA, Witte BI, Bos WH, et al. A prediction rule for the development of arthritis in seropositive arthralgia patients [J]. Ann Rheum Dis, 2013, 72(12):1920-1926.
10	Hemminki K, Li X, Sundquist J, et al. Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions [J]. Arthritis Rheum, 2009, 60(3):661-668.
11	Raychaudhuri S, Sandor C, Stahl E A, et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis [J]. Nat Genet, 2012, 44(3):291-296.
12	Gregersen P K, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis [J]. Arthritis Rheum, 1987, 30(11):1205-1213.
13	van der Woude D, Houwing-Duistermaat JJ, Toes RE, et al. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis [J]. Arthritis Rheum, 2009, 60(4):916-923.
14	Yarwood A, Huizinga TW, Worthington J. The genetics of rheumatoid arthritis: risk and protection in different stages of the evolution of RA [J]. Rheumatology (Oxford), 2016, 55(2):199-209.
15	Shi J, Knevel R, Suwannalai P, et al. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage [J]. Proc Natl Acad Sci U S A, 2011, 108(42):17372-17377.
16	Shi J, van de Stadt LA, Levarht EW, et al. Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis [J]. Arthritis Rheum, 2013, 65(4):911-915.
17	Kolfenbach JR, Deane KD, Derber LA, et al. Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis [J]. Arthritis Rheum, 2010, 62(9):2633-2639.
18	van de Stadt LA, de Vrieze H, Derksen NI, et al. Antibodies to IgG4 hinge can be found in rheumatoid arthritis patients during all stages of disease and may exacerbate chronic antibody-mediated inflammation [J]. Arthritis Rheumatol, 2014, 66(5):1133-1140.
19	Deane KD, Norris JM, Holers VM. Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigation [J]. Rheum Dis Clin North Am, 2010, 36(2):213-241.
20	Deane KD, O′Donnell CI, Hueber W, et al. The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner [J]. Arthritis Rheum, 2010, 62(11):3161-3172.
21	Nielen MM, van Schaardenburg D, Reesink HW, et al. Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis [J]. Arthritis Rheum, 2004, 50(8):2423-2427.
22	van Steenbergen HW, van Nies JA, Huizinga TW, et al. Characterising arthralgia in the preclinical phase of rheumatoid arthritis using MRI [J]. Ann Rheum Dis, 2015, 74(6):1225-1232.
23	van Steenbergen HW, Mangnus L, Reijnierse M, et al. Clinical factors, anticitrullinated peptide antibodies and MRI-detected subclinical inflammation in relation to progression from clinically suspect arthralgia to arthritis [J]. Ann Rheum Dis, 2016, 75(10):1824-1830.
24	Krabben A, Stomp W, van der Heijde DM, et al. MRI of hand and foot joints of patients with anticitrullinated peptide antibody positive arthralgia without clinical arthritis [J]. Ann Rheum Dis, 2013, 72(9):1540-1544.
25	van de Stadt LA, Bos WH, Meursinge RM, et al. The value of ultrasonography in predicting arthritis in auto-antibody positive arthralgia patients: a prospective cohort study [J]. Arthritis Res Ther, 2010, 12(3):R98.
26	Nam JL, Hensor EM, Hunt L, et al. Ultrasound findings predict progression to inflammatory arthritis in anti-CCP antibody-positive patients without clinical synovitis [J]. Ann Rheum Dis, 2016, 75(12):2060-2067.
27	Gent YY, Voskuyl AE, Kloet RW, et al. Macrophage positron emission tomography imaging as a biomarker for preclinical rheumatoid arthritis: findings of a prospective pilot study [J]. Arthritis Rheum, 2012, 64(1):62-66.
28	van Dongen H, van Aken J, Lard LR, et al. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial [J]. Arthritis Rheum, 2007, 56(5):1424-1432.
29	Verstappen SM, McCoy MJ, Roberts C, et al. Beneficial effects of a 3-week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: results of the STIVEA trial [J]. Ann Rheum Dis, 2010, 69(3):503-509.
30	Emery P, Durez P, Dougados M, et al. Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial) [J]. Ann Rheum Dis, 2010, 69(3):510-516.
31	Bos WH, Dijkmans BA, Boers M, et al. Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: a randomised trial [J]. Ann Rheum Dis, 2010, 69(3):571-574.
32	Cope AP. Emerging therapies for pre-RA[J]. Best Pract Res Clin Rheumatol, 2017, 31(1):99-111.

[1]	Min Zhao, Yilu Shi, Shasha Duan, Yaxi Wang, Jie Zhao, Haiyue Zhao, Lu Zhang, Tianhao Bai, Xiaoshan Zhang. Quantitative assessment of synovial neovascularization in rheumatoid arthritis by high-frequency contrast-enhanced ultrasound with arginylglycylaspartic acid microbubbles [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(05): 530-536.
[2]	Xuelan Li, Meng Yang, Chenyang Zhao, Ming Wang, Rui Zhang, Zhenhong Qi, Jianchu Li, Yuxin Jiang. Ultramicroangiography for evaluation of synovial blood flow in rheumatoid arthritis patients [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(02): 232-237.
[3]	Ming Wang, Meng Yang, Chenyang Zhao, Xixi Tao, Zhenhong Qi, Yixiu Zhang, Na Su, Rui Zhang, Tianhong Tang, Sirui Liu, Jianchu Li, Yuxin Jiang. Application of APP-based self-learning and testing mode in small joint ultrasound training [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2022, 19(01): 66-70.
[4]	Ling Gao, Zhe Yu, Ran Fan, Yinshan Zang. Evaluation value of peripheral blood cell count ratio for treatment efficacy of rheumatoid arthritis [J]. Chinese Journal of Joint Surgery(Electronic Edition), 2023, 17(05): 642-647.
[5]	Yuzi Wang, Xin Jin, Youhong Yuan. Study on relationship between linoleic acid intake and rheumatoid arthritis [J]. Chinese Journal of Joint Surgery(Electronic Edition), 2021, 15(01): 51-56.
[6]	Shunan Gu, Qi Li. Hydrogel drug delivery systems in treatment of rheumatoid arthritis [J]. Chinese Journal of Joint Surgery(Electronic Edition), 2020, 14(05): 597-601.
[7]	Jiandi He, Guo Tian, Shanyu Yin, Ying Hu, Liyun Zhong, Tianan Jiang, Qiyu Zhao. Efficacy of botulinum toxin injection for regional pain by ultrasonography: a meta-analysis [J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2021, 14(06): 484-488.
[8]	Bowen Wang, Linglong Zhao, Xuejun Yu, Bo Yang, Guoliang Wang, Wenliang Cao. Short-term efficacy observation of arthroscopic treatment for Larsen 3-4 stage rheumatoid elbow arthritis [J]. Chinese Journal of Shoulder and Elbow(Electronic Edition), 2023, 11(02): 128-131.
[9]	Yan Zhang, Fangyuan Qin, Rong Zhao, Wenjuan Qian, Yifeng Gu, Yabing Zhang. Correlation between leucine-rich A2 glycoprotein 1 and activity of rheumatoid arthritis [J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(11): 1126-1130.
[10]	Yafei Wang, Zhenbiao Wu. Application of autoantibodies in management of dermatomyositis patients [J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(08): 796-800.
[11]	An Chen, Xiao Cao, Huilin Zhang, Jianfeng Lian. Effects of acupuncture combined with Duhuo Jisheng decoction on erythrocyte sedimentation rate, C-reactive protein, and joint function in patients with rheumatoid arthritis [J]. Chinese Journal of Clinicians(Electronic Edition), 2021, 15(11): 877-881.
[12]	Yuelin Zhang, Jiaming Cao, Huiyuan Liu, Qiao Wang, Lingyu Fu. Association of miR-146a and miR-499 polymorphisms with susceptibility to rheumatoid arthritis: a Meta-analysis [J]. Chinese Journal of Clinicians(Electronic Edition), 2021, 15(06): 418-428.
[13]	Jun Zhou, Yinshan Zang, Zhe Yu, Yan Xu, Ling Gao. Effects of type 2 diabetes mellitus on curative effect of rheumatoid arthritis [J]. Chinese Journal of Clinicians(Electronic Edition), 2020, 14(09): 694-699.
[14]	Zejun Yang, Yin Zhao. Detection of autoantibodies in thrombophilia of pregnancy [J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(02): 76-80.
[15]	Jian Zhu, Yingli Wang, Zhigang Zhang. Professor Wang Yingli′s clinical experience in the application of bifengtong decoction [J]. Chinese Journal of Acupuncture and Moxibustion(Electronic Edition), 2021, 10(03): 131-132.

Please choose a citation manager

Content to export